These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24803988)

  • 1. Olive (Olea europaea) leaf extract induces apoptosis and monocyte/macrophage differentiation in human chronic myelogenous leukemia K562 cells: insight into the underlying mechanism.
    Samet I; Han J; Jlaiel L; Sayadi S; Isoda H
    Oxid Med Cell Longev; 2014; 2014():927619. PubMed ID: 24803988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antioxidant and anti-proliferative activity of the Lebanese Olea europaea extract.
    Fares R; Bazzi S; Baydoun SE; Abdel-Massih RM
    Plant Foods Hum Nutr; 2011 Mar; 66(1):58-63. PubMed ID: 21318304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of growth inhibition and differentiation of human leukemia HL-60 cells by a Tunisian gerboui olive leaf extract.
    Abaza L; Talorete TP; Yamada P; Kurita Y; Zarrouk M; Isoda H
    Biosci Biotechnol Biochem; 2007 May; 71(5):1306-12. PubMed ID: 17485840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Efficacy of Olive Leaf (
    Albogami S; Hassan AM
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis.
    Morandi F; Bensa V; Calarco E; Pastorino F; Perri P; Corrias MV; Ponzoni M; Brignole C
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells.
    Yen JH; Lin CY; Chuang CH; Chin HK; Wu MJ; Chen PY
    Cells; 2020 Apr; 9(4):. PubMed ID: 32260160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb.
    Zhang B; Zhang T; Zhang TY; Wang N; He S; Wu B; Jin HX
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential metabolomic analysis of the potential antiproliferative mechanism of olive leaf extract on the JIMT-1 breast cancer cell line.
    Barrajón-Catalán E; Taamalli A; Quirantes-Piné R; Roldan-Segura C; Arráez-Román D; Segura-Carretero A; Micol V; Zarrouk M
    J Pharm Biomed Anal; 2015 Feb; 105():156-162. PubMed ID: 25560707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angelica sinensis polysaccharide induces erythroid differentiation of human chronic myelogenous leukemia k562 cells.
    Wang L; Jiang R; Song SD; Hua ZS; Wang JW; Wang YP
    Asian Pac J Cancer Prev; 2015; 16(9):3715-21. PubMed ID: 25987027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytochemical properties and anti-proliferative activity of Olea europaea L. leaf extracts against pancreatic cancer cells.
    Goldsmith CD; Vuong QV; Sadeqzadeh E; Stathopoulos CE; Roach PD; Scarlett CJ
    Molecules; 2015 Jul; 20(7):12992-3004. PubMed ID: 26193251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
    Zhang C; Guo LY; Mu D; Gong JH; Chen J
    Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM; Liu JC
    J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhus verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells.
    Lee KW; Um ES; Jung BB; Choi ES; Kim EY; Lee S; Jang E; Lee JH; Kim Y
    Oncol Rep; 2018 Mar; 39(3):1141-1147. PubMed ID: 29328387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
    Lee YL; Chen CW; Liu FH; Huang YW; Huang HM
    PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
    Wei YL; Liang Y; Xu L; Zhao XY
    Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib.
    Yandim MK; Ceylan C; Elmas E; Baran Y
    Tumour Biol; 2016 Feb; 37(2):2365-78. PubMed ID: 26373734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.
    Shi D; Liu Y; Xi R; Zou W; Wu L; Zhang Z; Liu Z; Qu C; Xu B; Wang X
    Int J Nanomedicine; 2016; 11():5823-5835. PubMed ID: 27853367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.
    Jacquel A; Herrant M; Legros L; Belhacene N; Luciano F; Pages G; Hofman P; Auberger P
    FASEB J; 2003 Nov; 17(14):2160-2. PubMed ID: 14597677
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.
    Shiotsu Y; Neckers LM; Wortman I; An WG; Schulte TW; Soga S; Murakata C; Tamaoki T; Akinaga S
    Blood; 2000 Sep; 96(6):2284-91. PubMed ID: 10979978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.